CLVT Q1 2026 Earnings EPS Beat Lifts Sentiment but Revenue Uncertainty and Stock Decline Raise Caution FCRX Q1 2026 Earnings Narrow Miss on EPS Stable Note Performance BridgeBio Oncology Therapeutics Inc BBOT Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Slide BAC Q1 2026 Earnings Earnings Beat with 86 Surprise CXDO Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment Riskified Ltd RSKD Slips 252 as Stock Tests Key Support Levels Jasper Therapeutics JSPR Edges Higher as Stock Tests Key Resistance Near 096 Canadian Pacific Kansas City CP Rallies 225 Approaching Key Resistance at 9261 Nuveen Municipal Income Fund NEA Holds Steady Near Key Resistance After Minimal Move CRVS Q1 2026 Earnings EPS Slightly Misses Estimates Amid Continued Clinical Development